{"target_name": "KRAS", "paper_count": 30, "paper_count_year": {"1988": [1, 1, 2], "1989": [1, 0, 2], "1991": [1, 1, 0], "1993": [1, 0, 6], "1997": [1, 4, 2], "1998": [1, 5, 2], "2005": [1, 0, 13], "2006": [2, 8, 5], "2007": [3, 6, 4], "2008": [1, 6, 15], "2009": [3, 15, 32], "2010": [6, 19, 34], "2011": [6, 17, 42], "2012": [11, 18, 45], "2013": [9, 16, 59], "2014": [11, 13, 57], "2015": [15, 17, 42], "2016": [15, 22, 43], "2017": [13, 15, 56], "2018": [23, 20, 39], "2019": [34, 23, 31], "2020": [35, 25, 45], "2021": [34, 40, 38], "1911": [0, 1, 0], "1935": [0, 1, 0], "1940": [0, 1, 0], "1946": [0, 1, 0], "1949": [0, 2, 0], "1966": [0, 1, 0], "1971": [0, 1, 0], "1972": [0, 2, 1], "1976": [0, 1, 0], "1981": [0, 2, 1], "1982": [0, 1, 2], "1983": [0, 1, 3], "1987": [0, 4, 3], "1990": [0, 3, 3], "1992": [0, 2, 3], "1994": [0, 1, 7], "1995": [0, 3, 3], "1996": [0, 2, 0], "1999": [0, 4, 4], "2000": [0, 1, 4], "2001": [0, 2, 1], "2002": [0, 3, 6], "2003": [0, 9, 1], "2004": [0, 3, 7], "1832": [0, 0, 1], "1837": [0, 0, 1], "1894": [0, 0, 1], "1902": [0, 0, 1], "1903": [0, 0, 1], "1904": [0, 0, 2], "1909": [0, 0, 1], "1912": [0, 0, 1], "1914": [0, 0, 1], "1921": [0, 0, 3], "1922": [0, 0, 1], "1932": [0, 0, 1], "1939": [0, 0, 1], "1943": [0, 0, 3], "1945": [0, 0, 1], "1947": [0, 0, 1], "1948": [0, 0, 1], "1951": [0, 0, 2], "1958": [0, 0, 1], "1960": [0, 0, 1], "1961": [0, 0, 1], "1967": [0, 0, 3], "1968": [0, 0, 1], "1969": [0, 0, 2], "1970": [0, 0, 2], "1973": [0, 0, 2], "1977": [0, 0, 1], "1978": [0, 0, 1], "1979": [0, 0, 2], "1980": [0, 0, 2], "1984": [0, 0, 2], "1985": [0, 0, 2], "1986": [0, 0, 2]}, "drug_molecule_count": 16, "drug_molecule_paper": [{"id": 0, "paper_title": "RNA G-Quadruplexes in Kirsten Ras (KRAS) Oncogene as Targets for Small Molecules Inhibiting Translation", "paper_author": ["Giulia Miglietta", "Susanna Cogoi", "Jessica Marinello", "Giovanni Capranico", "Alexander S. Tikhomirov", "Andrey Shchekotikhin", "Luigi E. Xodo"], "paper_year": 2017, "paper_institution": "Department of Medicine, Biochemistry Laboratory, University of Udine, 33100 Udine, Italy", "paper_cited": 38, "doi": "10.1021/acs.jmedchem.7b00622", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-23/acs.jmedchem.7b00622/20171215/images/large/jm-2017-006225_0012.jpeg", "compound_count": 13, "compound_name": "20", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 1, "paper_title": "Discovery of Novel PDEδ Degraders for the Treatment of KRAS Mutant Colorectal Cancer", "paper_author": ["Junfei Cheng", "Yu Li", "Xu Wang", "Guoqiang Dong", "Chunquan Sheng"], "paper_year": 2020, "paper_institution": "", "paper_cited": 6, "doi": "10.1021/acs.jmedchem.0c00929", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-14/acs.jmedchem.0c00929/20200716/images/large/jm0c00929_0012.jpeg", "compound_count": 32, "compound_name": "10", "compound_name_drug": "", "compound_smiles": "O=C1C(N2C(=O)c3cccc(NCCCCCCCCNC(=O)CCCn4c(=O)c5c(c(n4)C)c(C)n(n5)c4ccc(C)cc4)c3C2=O)CCC(=O)N1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 2, "paper_title": "Identification of a New G-Quadruplex Motif in the KRAS Promoter and Design of Pyrene-Modified G4-Decoys with Antiproliferative Activity in Pancreatic Cancer Cells", "paper_author": ["Susanna Cogoi", "Manikandan Paramasivam", "Vyacheslav Filichev", "Imrich Géci", "Erik B. Pedersen", "Luigi E. Xodo"], "paper_year": 2008, "paper_institution": "Department of Biomedical Science and Technology, School of Medicine, P.le Kolbe 4, 33100 Udine, Italy, Institute of Fundamental Sciences, Massey University, Palmerston North, New Zealand, Nucleic Acid Center, Institute of Physics and Chemistry, University of Southern Denmark, DK-5230 Odense M, Denmark", "paper_cited": 67, "doi": "10.1021/jm800874t", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-2/jm800874t/production/images/large/jm-2008-00874t_0008.jpeg", "compound_count": 21, "compound_name": "637", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 3, "paper_title": "Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3H)-quinazolinone Aryl Urea pan-RAF Kinase Inhibitor", "paper_author": ["Malcolm P. Huestis", "Darlene Dela Cruz", "Antonio G. DiPasquale", "Matthew R. Durk", "Charles Eigenbrot", "Paul Gibbons", "Alberto Gobbi", "Thomas L. Hunsaker", "Hank La", "Dennis H. Leung", "Wendy Liu", "Shiva Malek", "Mark Merchant", "John G. Moffat", "Christine S. Muli", "Christine J. Orr", "Brendan T. Parr", "Frances Shanahan", "Christopher J. Sneeringer", "Weiru Wang", "Ivana Yen", "Jianping Yin", "Michael Siu", "Joachim Rudolph"], "paper_year": 2021, "paper_institution": "", "paper_cited": 1, "doi": "10.1021/acs.jmedchem.0c02085", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-7/acs.jmedchem.0c02085/20210331/images/large/jm0c02085_0013.jpeg", "compound_count": 24, "compound_name": "1", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 4, "paper_title": "Photodynamic Therapy for ras-Driven Cancers: Targeting G-Quadruplex RNA Structures with Bifunctional Alkyl-Modified Porphyrins", "paper_author": ["Annalisa Ferino", "Giulia Nicoletto", "Francesca D’Este", "Sonia Zorzet", "Sara Lago", "Sara N. Richter", "Alexander Tikhomirov", "Andrey Shchekotikhin", "Luigi E. Xodo"], "paper_year": 2020, "paper_institution": "", "paper_cited": 11, "doi": "10.1021/acs.jmedchem.9b01577", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01577/20210113/images/large/jm9b01577_0011.jpeg", "compound_count": 10, "compound_name": "16", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 5, "paper_title": "Design and Discovery of N-(2-Methyl-5′-morpholino-6′-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3′-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers", "paper_author": ["Gisele A. Nishiguchi", "Alice Rico", "Huw Tanner", "Robert J. Aversa", "Benjamin R. Taft", "Sharadha Subramanian", "Lina Setti", "Matthew T. Burger", "Lifeng Wan", "Victoriano Tamez", "Aaron Smith", "Yan Lou", "Paul A. Barsanti", "Brent A. Appleton", "Mulugeta Mamo", "Laura Tandeske", "Ina Dix", "John E. Tellew", "Shenlin Huang", "Lesley A. Mathews Griner", "Vesselina G. Cooke", "Anne Van Abbema", "Hanne Merritt", "Sylvia Ma", "Kalyani Gampa", "Fei Feng", "Jing Yuan", "Yingyun Wang", "Jacob R. Haling", "Sepideh Vaziri", "Mohammad Hekmat-Nejad", "Johanna M. Jansen", "Valery Polyakov", "Richard Zang", "Vijay Sethuraman", "Payman Amiri", "Mallika Singh", "Emma Lees", "Wenlin Shao", "Darrin D. Stuart", "Michael P. Dillon", "Savithri Ramurthy"], "paper_year": 2017, "paper_institution": "Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States", "paper_cited": 21, "doi": "10.1021/acs.jmedchem.6b01862", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-12/acs.jmedchem.6b01862/20170616/images/large/jm-2016-01862v_0017.jpeg", "compound_count": 32, "compound_name": "14", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 1.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 48.0}, "clinical_statistics": {}}, {"id": 6, "paper_title": "Discovery of 1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a Pan-RAF Inhibitor with Minimal Paradoxical Activation and Activity against BRAF or RAS Mutant Tumor Cells", "paper_author": ["James R. Henry", "Michael D. Kaufman", "Sheng-Bin Peng", "Yu Mi Ahn", "Timothy M. Caldwell", "Lakshminarayana Vogeti", "Hanumaiah Telikepalli", "Wei-Ping Lu", "Molly M. Hood", "Thomas J. Rutkoski", "Bryan D. Smith", "Subha Vogeti", "David Miller", "Scott C. Wise", "Lawrence Chun", "Xiaoyi Zhang", "Youyan Zhang", "Lisa Kays", "Philip A. Hipskind", "Aaron D. Wrobleski", "Karen L. Lobb", "Julia M. Clay", "Jeffrey D. Cohen", "Jennie L. Walgren", "Denis McCann", "Phenil Patel", "David K. Clawson", "Sherry Guo", "Danalyn Manglicmot", "Chris Groshong", "Cheyenne Logan", "James J. Starling", "Daniel L. Flynn"], "paper_year": 2015, "paper_institution": "Eli Lilly and Company, Indianapolis, Indiana 46285, United States", "paper_cited": 50, "doi": "10.1021/acs.jmedchem.5b00067", "paper_journal": "Journal of Medicinal Chemistry", "paper_abstract_image": "https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00067/20150521/images/large/jm-2015-000678_0016.jpeg", "compound_count": 44, "compound_name": "13", "compound_name_drug": "LY3009120", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 5.8, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 44.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {"p1_company_num": 1, "p1_stat_company_num": [0, 0, 0, 0, 0, 1, 0, 0, 0], "p1_company": [[], [], [], [], [], ["Eli Lilly and Company"], [], [], []], "p1_terminate_reason": {"Eli Lilly and Company": "Progressive Disease"}, "p1_withdraw_reason": {}, "p1_adverse_event": {"Eli Lilly and Company": 0.0}, "p2_company_num": 0, "p2_stat_company_num": [0, 0, 0, 0, 0, 0, 0, 0, 0], "p2_company": [[], [], [], [], [], [], [], [], []], "p2_terminate_reason": {}, "p2_withdraw_reason": {}, "p2_adverse_event": {}, "p3_company_num": 0, "p3_stat_company_num": [0, 0, 0, 0, 0, 0, 0, 0, 0], "p3_company": [[], [], [], [], [], [], [], [], []], "p3_terminate_reason": {}, "p3_withdraw_reason": {}, "p3_adverse_event": {}}}, {"id": 7, "paper_title": "Scaffold repurposing of fendiline: Identification of potent KRAS plasma membrane localization inhibitors", "paper_author": ["Pingyuan Wang", "Dharini van der Hoeven", "Na Ye", "Haiying Chen", "Zhiqing Liu", "Xiaoping Ma", "Dina Montufar-Solis", "Kristen M. Rehl", "Kwang-Jin Cho", "Sabita Thapa", "Wei Chen", "Ransome van der Hoeven", "Jeffrey A. Frost", "John F. Hancock", "Jia Zhou"], "paper_year": 2021, "paper_institution": "Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, 77555, USA", "paper_cited": 0, "doi": "10.1016/j.ejmech.2021.113381", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002300-ga1_lrg.jpg", "compound_count": 29, "compound_name": "12f", "compound_name_drug": "", "compound_smiles": "C1N(CCC1)CCN([C@@H](c1ccc(OC)cc1)C)CC=C(c1ccccc1)c1ccccc1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 100.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 8, "paper_title": " inhibitors", "paper_author": ["Xuanzheng Xiao", "Mengzhen Lai", "Zilan Song", "Meiyu Geng", "Jian Ding", "Hua Xie", "Ao Zhang"], "paper_year": 2021, "paper_institution": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, 201203, China", "paper_cited": 0, "doi": "10.1016/j.ejmech.2020.113082", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523420310540-fx1_lrg.jpg", "compound_count": 19, "compound_name": "26a", "compound_name_drug": "", "compound_smiles": "c1(ccnc2c1n1c3c(c(c4c(F)cccc4O)ncc3c(nc1=[O]C2C)N1[C@H](CN(CC1)C(=O)C=C)C)F)C", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 9, "paper_title": "\n            ", "paper_author": ["Li-li Xu", "Cui-cui Li", "Lu-yan An", "Zhen Dai", "Xiao-yi Chen", "Qi-dong You", "Chi Hu", "Bin Di"], "paper_year": 2020, "paper_institution": "Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 210009, China", "paper_cited": 4, "doi": "10.1016/j.ejmech.2019.111844", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523419309961-fx1_lrg.jpg", "compound_count": 0, "compound_name": "649", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 10, "paper_title": "Substituted tetrahydroisoquinolines: synthesis, characterization, antitumor activity and other biological properties", "paper_author": ["A. Sergi Capilla", "Richard Soucek", "Laura Grau", "Manel Romero", "Jaime Rubio-Martínez", "Daniel H. Caignard", "Maria Dolors Pujol"], "paper_year": 2018, "paper_institution": "Laboratori de Química Farmacèutica (Unitat associada al CSIC), Facultat de Farmàcia, Universitat de Barcelona, Spain", "paper_cited": 9, "doi": "10.1016/j.ejmech.2017.12.098", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523417311297-fx1_lrg.jpg", "compound_count": 18, "compound_name": "12", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 2600.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 11, "paper_title": "Synthesis and anti-tumor activity of imidazopyrazines as TAK1 inhibitors", "paper_author": ["Seok Jong Kang", "Jung Wuk Lee", "Shin Hyuck Chung", "Sun Young Jang", "Jaeyul Choi", "Kwee Hyun Suh", "Young Hoon Kim", "Young Jin Ham", "Kyung Hoon Min"], "paper_year": 2019, "paper_institution": "College of Pharmacy, Chung-Ang University, Seoul, 06974, Republic of Korea", "paper_cited": 2, "doi": "10.1016/j.ejmech.2018.12.025", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418310626-fx1_lrg.jpg", "compound_count": 21, "compound_name": "22a", "compound_name_drug": "", "compound_smiles": "N(C1CC1)c1c2nccn2c(cn1)c1c(C)cc(NC(=O)Nc2n(nc(C(C)(C)C)c2)c2ccccc2)cc1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 274.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 3144.0, "solubility": 0.0, "t_half": 1.6, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 12, "paper_title": "Discovery of potent, orally bioavailable ERK1/2 inhibitors with isoindolin-1-one structure by structure-based drug design", "paper_author": ["Dezhong Ji", "Lingzhi Zhang", "Qihua Zhu", "Ying Bai", "Yaoyao Wu", "Yungen Xu"], "paper_year": 2019, "paper_institution": "Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, 21009, China", "paper_cited": 3, "doi": "10.1016/j.ejmech.2018.12.040", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418310778-fx1_lrg.jpg", "compound_count": 0, "compound_name": "1500", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 13, "paper_title": "Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy", "paper_author": ["Satish Sagar", "Sarbjit Singh", "Jayapal Reddy Mallareddy", "Yogesh A. Sonawane", "John V. Napoleon", "Sandeep Rana", "Jacob I. Contreras", "Christabelle Rajesh", "Edward L. Ezell", "Smitha Kizhake", "Jered C. Garrison", "Prakash Radhakrishnan", "Amarnath Natarajan"], "paper_year": 2021, "paper_institution": "Eppley Institute for Cancer Research, Omaha, NE, USA", "paper_cited": 0, "doi": "10.1016/j.ejmech.2021.113579", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421004281-ga1_lrg.jpg", "compound_count": 0, "compound_name": "84", "compound_name_drug": "", "compound_smiles": "", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 14, "paper_title": "Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer", "paper_author": ["Huan Tang", "Yongguang Zhang", "Dan Li", "Suhong Fu", "Minghai Tang", "Li Wan", "Kai Chen", "Zhuowei Liu", "Linlin Xue", "Aihua Peng", "Haoyu Ye", "Lijuan Chen"], "paper_year": 2018, "paper_institution": "State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, PR China", "paper_cited": 15, "doi": "10.1016/j.ejmech.2018.06.048", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523418305397-fx1_lrg.jpg", "compound_count": 18, "compound_name": "00", "compound_name_drug": "", "compound_smiles": "C(C=C)c1cc(CN2CCC(N)CC2)c(O)c(c2cc(CC=C)ccc2O)c1", "medicinal_chemistry_metrics": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 0.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 0.0, "bioavailability": 0.0}, "clinical_statistics": {}}, {"id": 15, "paper_title": "\n            ", "paper_author": ["Yi-Min Liu", "Huang-Ju Tu", "Chueh-Heng Wu", "Mei-Jung Lai", "Shu-Chieh Yu", "Min-Wu Chao", "Yi-Wen Wu", "Che-Ming Teng", "Shiow-Lin Pan", "Jing-Ping Liou"], "paper_year": 2021, "paper_institution": "School of Pharmacy, College of Pharmacy, Taipei Medical University, 250 Wuxing Street, Taipei, 11031, Taiwan", "paper_cited": 0, "doi": "10.1016/j.ejmech.2021.113428", "paper_journal": "European Journal of Medicinal Chemistry", "paper_abstract_image": "https://api.elsevier.com/content/object/eid/1-s2.0-S0223523421002774-ga1_lrg.jpg", "compound_count": 11, "compound_name": "6b", "compound_name_drug": "", "compound_smiles": "c1(cnccc1)N(C(=O)c1c(cc(O)c(C(C)C)c1)O)CC", "medicinal_chemistry_metrics": {"Ki": 200.0, "Kd": 0.0, "IC50": 50.0, "selectivity": 0}, "pharm_metrics_vitro": {"Ki": 0.0, "Kd": 0.0, "IC50": 110180.0, "EC50": 0.0, "selectivity": 0, "hERG": 0.0, "solubility": 0.0}, "pharm_metrics_vivo": {"ED50": 0.0, "AUC": 0.0, "solubility": 0.0, "t_half": 5.31, "bioavailability": 0.0}, "clinical_statistics": {}}], "medicinal_chemistry_similarity": [{"source": 0, "target": 1, "value": 0.0}, {"source": 0, "target": 2, "value": 1.0}, {"source": 0, "target": 3, "value": 1.0}, {"source": 0, "target": 4, "value": 1.0}, {"source": 0, "target": 5, "value": 1.0}, {"source": 0, "target": 6, "value": 1.0}, {"source": 0, "target": 7, "value": 0.0}, {"source": 0, "target": 8, "value": 0.0}, {"source": 0, "target": 9, "value": 1.0}, {"source": 0, "target": 10, "value": 1.0}, {"source": 0, "target": 11, "value": 0.0}, {"source": 0, "target": 12, "value": 1.0}, {"source": 0, "target": 13, "value": 1.0}, {"source": 0, "target": 14, "value": 0.0}, {"source": 0, "target": 15, "value": 0.0}, {"source": 1, "target": 2, "value": 0.0}, {"source": 1, "target": 3, "value": 0.0}, {"source": 1, "target": 4, "value": 0.0}, {"source": 1, "target": 5, "value": 0.0}, {"source": 1, "target": 6, "value": 0.0}, {"source": 1, "target": 7, "value": 0.27379553466509987}, {"source": 1, "target": 8, "value": 0.0}, {"source": 1, "target": 9, "value": 0.0}, {"source": 1, "target": 10, "value": 0.0}, {"source": 1, "target": 11, "value": 0.5864661654135338}, {"source": 1, "target": 12, "value": 0.0}, {"source": 1, "target": 13, "value": 0.0}, {"source": 1, "target": 14, "value": 0.31878230901780585}, {"source": 1, "target": 15, "value": 0.38250428816466553}, {"source": 2, "target": 3, "value": 1.0}, {"source": 2, "target": 4, "value": 1.0}, {"source": 2, "target": 5, "value": 1.0}, {"source": 2, "target": 6, "value": 1.0}, {"source": 2, "target": 7, "value": 0.0}, {"source": 2, "target": 8, "value": 0.0}, {"source": 2, "target": 9, "value": 1.0}, {"source": 2, "target": 10, "value": 1.0}, {"source": 2, "target": 11, "value": 0.0}, {"source": 2, "target": 12, "value": 1.0}, {"source": 2, "target": 13, "value": 1.0}, {"source": 2, "target": 14, "value": 0.0}, {"source": 2, "target": 15, "value": 0.0}, {"source": 3, "target": 4, "value": 1.0}, {"source": 3, "target": 5, "value": 1.0}, {"source": 3, "target": 6, "value": 1.0}, {"source": 3, "target": 7, "value": 0.0}, {"source": 3, "target": 8, "value": 0.0}, {"source": 3, "target": 9, "value": 1.0}, {"source": 3, "target": 10, "value": 1.0}, {"source": 3, "target": 11, "value": 0.0}, {"source": 3, "target": 12, "value": 1.0}, {"source": 3, "target": 13, "value": 1.0}, {"source": 3, "target": 14, "value": 0.0}, {"source": 3, "target": 15, "value": 0.0}, {"source": 4, "target": 5, "value": 1.0}, {"source": 4, "target": 6, "value": 1.0}, {"source": 4, "target": 7, "value": 0.0}, {"source": 4, "target": 8, "value": 0.0}, {"source": 4, "target": 9, "value": 1.0}, {"source": 4, "target": 10, "value": 1.0}, {"source": 4, "target": 11, "value": 0.0}, {"source": 4, "target": 12, "value": 1.0}, {"source": 4, "target": 13, "value": 1.0}, {"source": 4, "target": 14, "value": 0.0}, {"source": 4, "target": 15, "value": 0.0}, {"source": 5, "target": 6, "value": 1.0}, {"source": 5, "target": 7, "value": 0.0}, {"source": 5, "target": 8, "value": 0.0}, {"source": 5, "target": 9, "value": 1.0}, {"source": 5, "target": 10, "value": 1.0}, {"source": 5, "target": 11, "value": 0.0}, {"source": 5, "target": 12, "value": 1.0}, {"source": 5, "target": 13, "value": 1.0}, {"source": 5, "target": 14, "value": 0.0}, {"source": 5, "target": 15, "value": 0.0}, {"source": 6, "target": 7, "value": 0.0}, {"source": 6, "target": 8, "value": 0.0}, {"source": 6, "target": 9, "value": 1.0}, {"source": 6, "target": 10, "value": 1.0}, {"source": 6, "target": 11, "value": 0.0}, {"source": 6, "target": 12, "value": 1.0}, {"source": 6, "target": 13, "value": 1.0}, {"source": 6, "target": 14, "value": 0.0}, {"source": 6, "target": 15, "value": 0.0}, {"source": 7, "target": 8, "value": 0.0}, {"source": 7, "target": 9, "value": 0.0}, {"source": 7, "target": 10, "value": 0.0}, {"source": 7, "target": 11, "value": 0.24884488448844885}, {"source": 7, "target": 12, "value": 0.0}, {"source": 7, "target": 13, "value": 0.0}, {"source": 7, "target": 14, "value": 0.3369447453954496}, {"source": 7, "target": 15, "value": 0.2988505747126437}, {"source": 8, "target": 9, "value": 0.0}, {"source": 8, "target": 10, "value": 0.0}, {"source": 8, "target": 11, "value": 0.0}, {"source": 8, "target": 12, "value": 0.0}, {"source": 8, "target": 13, "value": 0.0}, {"source": 8, "target": 14, "value": 0.0}, {"source": 8, "target": 15, "value": 0.0}, {"source": 9, "target": 10, "value": 1.0}, {"source": 9, "target": 11, "value": 0.0}, {"source": 9, "target": 12, "value": 1.0}, {"source": 9, "target": 13, "value": 1.0}, {"source": 9, "target": 14, "value": 0.0}, {"source": 9, "target": 15, "value": 0.0}, {"source": 10, "target": 11, "value": 0.0}, {"source": 10, "target": 12, "value": 1.0}, {"source": 10, "target": 13, "value": 1.0}, {"source": 10, "target": 14, "value": 0.0}, {"source": 10, "target": 15, "value": 0.0}, {"source": 11, "target": 12, "value": 0.0}, {"source": 11, "target": 13, "value": 0.0}, {"source": 11, "target": 14, "value": 0.3049095607235142}, {"source": 11, "target": 15, "value": 0.36086404066073696}, {"source": 12, "target": 13, "value": 1.0}, {"source": 12, "target": 14, "value": 0.0}, {"source": 12, "target": 15, "value": 0.0}, {"source": 13, "target": 14, "value": 0.0}, {"source": 13, "target": 15, "value": 0.0}, {"source": 14, "target": 15, "value": 0.37662337662337664}], "metrics_paper_count": {"IC50_MC": 3, "Ki_MC": 1, "Kd_MC": 0, "Selectivity_MC": 0, "IC50_Ph": 4, "Ki_Ph": 0, "Kd_Ph": 0, "EC50_Ph": 0, "Selectivity_Ph": 0, "hERG_Ph": 0, "solubility_Ph": 0, "ED50_Cl": 0, "thalf_Cl": 2, "AUC_Cl": 2, "bio_Cl": 1, "solubility_Cl": 0, "adverse_1": 1, "adverse_2": 0, "adverse_3": 0}, "metrics_distribution": {"IC50_MC": [5.8, 100.0, 50.0], "Ki_MC": [200.0], "Kd_MC": [], "Selectivity_MC": [], "IC50_Ph": [44.0, 2600.0, 274.0, 110180.0], "Ki_Ph": [], "Kd_Ph": [], "EC50_Ph": [], "Selectivity_Ph": [], "hERG_Ph": [], "solubility_Ph": [], "ED50_Cl": [], "thalf_Cl": [1.6, 5.31], "AUC_Cl": [1.0, 3144.0], "bio_Cl": [48.0], "solubility_Cl": [], "adverse_1": [0.0], "adverse_2": [], "adverse_3": []}}